Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

समान संसाधन

• Effects of PKC412, nilotinib and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity: Mutant PDGFRA: PKC412, nilotinib, imatinib
  द्वारा: Weisberg, Ellen, और अन्य
  प्रकाशित: (2006)
• Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation
  द्वारा: Metzgeroth, Georgia, और अन्य
  प्रकाशित: (2020)
• Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature
  द्वारा: Socola, Francisco, और अन्य
  प्रकाशित: (2017)
• Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
  द्वारा: Bain, Barbara J.
  प्रकाशित: (2010)
• A dramatic case of non-episodic angioedema with eosinophilia
  द्वारा: Clements-Baker, M, और अन्य
  प्रकाशित: (2010)